Mach 1 Financial Group, LLC Amgen Inc Transaction History

Mach 1 Financial Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$225.79 - $275.2 $60,511 - $73,753	268 New	268 $64,000
Q2 2022 Aug 04, 2022	BUY	$230.71 - $256.74 $52,601 - $58,536	228 Added 112.32%	431 $104,000
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $40,372 - $46,202	203 New	203 $45,000
Q3 2021 Oct 18, 2021	SELL	$212.27 - $248.7 $43,090 - $50,486	-203 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $45,047 - $52,495	203 New	203 $50,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $151B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Mach 1 Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Mach 1 Financial Group, LLC with notifications on news.